Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives

Approximately 5%–10% of asthmatics suffer from severe asthma. New biological treatments represent a great opportunity to reduce asthma burden and to improve asthma patients’ lives. Reslizumab will soon be available in several European countries. This anti-IL-5 IgG4/κ monoclonal antibody, administere...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Patient Relat Outcome Meas
Main Authors: Padilla Galo, Alicia, Labor, Marina, Tiotiu, Angelica, Baiardini, Ilaria, Scichilone, Nicola, Braido, Fulvio
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6103306/
https://ncbi.nlm.nih.gov/pubmed/30147386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PROM.S146966
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker